A nurse is administering pancrelipase to a child who has cystic fibrosis. Which of the following outcomes should the nurse expect as a therapeutic effect of the treatment?

A. Correct. Pancre-lipase is an enzyme replacement therapy used in cystic fibrosis to improve digestion and absorption of fats. Reduction in fat in the stools indicates improved fat digestion. B. Improved absorption of vitamins B and C might occur as a result of improved overall digestion, but it is not the primary therapeutic effect of pancre-lipase. C. Improved respiratory function is not a direct effect of pancre-lipase. D. Decreased sodium excretion is not a primary therapeutic effect of pancre-lipase.